Analysis of predictive factors of unforeseen nodal metastases in resected clinical stage I NSCLC

被引:2
|
作者
Gallina, Filippo Tommaso [1 ]
Marinelli, Daniele [2 ]
Taje, Riccardo [1 ]
Forcella, Daniele [1 ]
Alessandrini, Gabriele [1 ]
Cecere, Fabiana Letizia [3 ]
Fusco, Francesca [3 ]
Visca, Paolo [4 ]
Sperduti, Isabella [5 ]
Ambrogi, Vincenzo [6 ]
Cappuzzo, Federico [3 ]
Melis, Enrico [1 ]
Facciolo, Francesco [1 ]
机构
[1] IRCCS Regina Elena Natl Canc Inst, Thorac Surg Unit, Rome, Italy
[2] Sapienza Univ Rome, Dept Expt Med, Rome, Italy
[3] IRCCS Regina Elena Natl Canc Inst, Med Oncol 2, Rome, Italy
[4] IRCCS Regina Elena Natl Canc Inst, Dept Pathol, Rome, Italy
[5] IRCCS Regina Elena Natl Canc Inst, Biostat, Rome, Italy
[6] Tor Vergata Policlin, Dept Thorac Surg, Rome, Italy
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
early stage NSCLC; upstaging; stage I; nodal disease; lymphadenectomy; LUNG; PATTERNS; N1;
D O I
10.3389/fonc.2023.1229939
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundDespite notable advances made in preoperative staging, unexpected nodal metastases after surgery are still significantly detected. In this study we aim to analyze the upstaging rate in patients with clinical stage I NSCLC without evidence of nodal disease in the preoperative staging who underwent lobectomy and radical lymphadenectomy.MethodsPatients who underwent lobectomy and systematic lymphadenectomy for clinical stage I NSCLC were evaluated. Exclusion criteria included the neoadjuvant treatment, incomplete resection and no adherence to preoperative guidelines.ResultsA total of 297 patients were included in the study. 159 patients were female, and the median age was 68 (61 - 73). The variables that showed a significant correlation with the upstaging rate at the univariate analysis were the number of resected lymph nodes and micropapillar/solid adenocar-cinoma subtype. This result was confirmed in the multivariate analysis with a OR= 2.545 (95%CI 1.136-5.701; p=0.02) for the number of resected lymph nodes and a OR=2.717 (95%CI 1.256-5.875; p=0.01) for the high-grade pattern of adenocarcinoma.ConclusionOur results showed that in a homogeneous cohort of patients with clinical stage I NSCLC, the number of resected lymph nodes and the histological subtype of adenocarcinoma can significantly be associated with nodal metastasis.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Lobe-Specific Nodal Dissection for Clinical Stage I and II NSCLC: Japanese Multi-Institutional Retrospective Study Using a Propensity Score Analysis
    Hishida, Tomoyuki
    Miyaoka, Etsuo
    Yokoi, Kohei
    Tsuboi, Masahiro
    Asamura, Hisao
    Kiura, Katsuyuki
    Takahashi, Kazuhisa
    Dosaka-Akita, Hirotoshi
    Kobayashi, Hideo
    Date, Hiroshi
    Tada, Hirohito
    Okumura, Meinoshin
    Yoshino, Ichiro
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (09) : 1529 - 1537
  • [32] Clinical management and outcomes of completely resected stage I follicular lymphoma
    Yokohama, Akihiko
    Hashimoto, Yoko
    Takizawa, Makiko
    Shimizu, Hiroaki
    Miyazawa, Yuri
    Saitoh, Akio
    Toyama, Kohtaro
    Ishizaki, Takuma
    Mitsui, Takeki
    Koiso, Hiromi
    Saitoh, Takayuki
    Murayama, Kayoko
    Matsumoto, Morio
    Sawamura, Morio
    Murakami, Hirokazu
    Hirato, Junko
    Kojima, Masaru
    Nojima, Yoshihisa
    Handa, Hiroshi
    Tsukamoto, Norifumi
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2018, 58 (01) : 10 - 16
  • [33] Analysis of the p38MAPK pathway in the prognosis of patients with surgically resected stage I-II NSCLC.
    Pardo-Coto, Pablo
    Esteban, Emilio
    Astudillo, Aurora
    Manuel Gracia, Jose
    Corral, Norberto
    Izquierdo Manuel, Marta
    Muriel Lopez, Carolina
    Sanmamed, Miguel F.
    Gutierrez Restrepo, Eduardo
    Valle Pereda, Miguel
    Alvarez Fernandez, Carlos
    Perez Arnillas, Quionia
    Berros Fombella, Jose Pablo
    Jimenez, Paula
    Maria Vieitez de Prado, Jose
    Fra, Joaquin
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [34] Determinants of clinical and pathological stage discordance in resected NSCLC patients: A retrospective observational cohort study
    Samuel, E.
    Thomas, C.
    Thompson, C.
    Paul, E.
    Scholz, S. A.
    Zhang, L.
    Grewal, J. K.
    Cox, J. D.
    Yu, C.
    Adabi, G.
    Taverner, J.
    Zalcberg, J. R.
    Stirling, R. G.
    ANNALS OF ONCOLOGY, 2021, 32 : S937 - S937
  • [35] Predictors and Consequences of Refusing Surgery for Clinical Stage I NSCLC: A National Cancer Database Analysis
    Rahouma, M.
    Kamel, M.
    Nasar, A.
    Harrison, S.
    Lee, B.
    Port, J.
    Altorki, N.
    Stiles, B.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S335 - S335
  • [36] Predictive factors for survival in surgically resected clinical IA peripheral adenocarcinoma of the lung
    Sakao, Y
    Nakazono, T
    Sakuragi, T
    Natsuaki, M
    Itoh, T
    ANNALS OF THORACIC SURGERY, 2004, 77 (04): : 1157 - 1162
  • [37] Retrospective analysis of risk factors and clinical significance of clinical stage I endometrioid adenocarcinoma
    Li, Baohua
    CANCER SCIENCE, 2018, 109 : 424 - 424
  • [38] HIGH RISK FEATURES IMPROVE PROGNOSTICATION IN RESECTED STAGE I NSCLC: A SINGLE INSTITUTION RETROSPECTIVE REVIEW
    Hansen, Aaron R.
    Colosimo, Maree
    Clarke, Belinda E.
    Duhig, Edwina E.
    Matar, Kevin
    Windsor, Morgan
    Bowman, Rayleen
    Yang, Ian A.
    Fong, Kwun M.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1331 - S1332
  • [39] Identifying factors associated with increased mortality risk in stage I NSCLC
    Nature Clinical Practice Oncology, 2008, 5 (2): : 64 - 64
  • [40] Defining Factors That Allow for a More Personalized Approach to Stage I NSCLC
    Donington, Jessica S.
    JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (08):